Fractyl Health offers a high-risk, high-reward setup with a near-term binary catalyst in the REMAIN-1 cohort data expected Q3 ...

After 12 weeks of treatment, 75% of per-protocol patients receiving 0.05% urcosimod showed greater than 80% reduction in ...

It is widely accepted that sugar and foods high in sugar will make a child or young person hyperactive and extremely energetic. However, research conducted over the last 20 years has shown that sugar ...

Esketamine monotherapy is linked to greater 28-day symptom reduction in treatment-resistant depression vs placebo, new research shows.

If you regularly experience headaches, add these foods to your diet to relieve the pain and uncomfortable symptoms.

Monjuvi added to Rituxan and Revlimid extended progression-free survival from 14 to 22 months in follicular lymphoma, ...

Setmelanotide was associated with significant weight reduction among patients aged 4 years and older with acquired hypothalamic obesity.

What you eat could be the key to easing your headache or migraine symptoms. Though adjusting your diet is far from a miracle ...

An oral melanocortin-4 receptor agonist conferred significant BMI reductions among adolescents and adults with hypothalamic ...

The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing ...

This study was designed "to detect differences between individualized homeopathic medicinal products (IHMPs) and placebo after 4 months of intervention in patients with chronic low-back pain (LBP)".

A motion sickness drug that treats severe depression in hours? Discover how scopolamine may revolutionize mental health ...